on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation..

. april 2009  (19). taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..

elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital..